Gene · 4593
Papers3,141
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
721 to 740 of 3,141
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Cumulative Detrimental Effect of COVID-19 Pneumonia in a Patient with Myasthenic Crisis: A Case Report and Overview of the Literature. | Life (Basel) | 2022 | 36294917 | PubTator, text mining | PubMed |
| Combining Gene Mutation with Expression of Candidate Genes to Improve Diagnosis of Escobar Syndrome. | Genes (Basel) | 2022 | 36292632 | PubTator, text mining | PubMed |
| Identification of the Factor That Leads Human Mesenchymal Stem Cell Lines into Decellularized Bone. | Bioengineering (Basel) | 2022 | 36290460 | PubTator, text mining | PubMed |
| Newborn Screening for Duchenne Muscular Dystrophy: First Year Results of a Population-Based Pilot. | Int J Neonatal Screen | 2022 | 36278620 | PubTator, text mining | PubMed |
| Effects of different weaning times on the stress response and the intestinal microbiota composition of female forest musk deer (Moschus berezovskii) and their fawns. | PLoS One | 2022 | 36264997 | PubTator, text mining | PubMed |
| Outcomes and characteristics of myasthenia gravis: A 10-year retrospective cross-sectional study at King Fahad Medical City. | Neurosciences (Riyadh) | 2022 | 36252965 | PubTator, text mining | PubMed |
| Knowledge mapping of targeted immunotherapy for myasthenia gravis from 1998 to 2022: A bibliometric analysis. | Front Immunol | 2022 | 36248874 | PubTator, text mining | PubMed |
| Clinical characteristics and outcome predictors of a Chinese childhood-onset myasthenia gravis cohort. | Front Pediatr | 2022 | 36245736 | PubTator, text mining | PubMed |
| Enrichment of serum IgG4 in MuSK myasthenia gravis patients. | J Neuroimmunol | 2022 | 36240543 | PubTator, text mining | PubMed |
| The two facets of receptor tyrosine kinase in cardiovascular calcification-can tyrosine kinase inhibitors benefit cardiovascular system? | Front Cardiovasc Med | 2022 | 36237897 | PubTator, text mining | PubMed |
| Immune Checkpoint Inhibitor-Induced Myositis/Myocarditis with Myasthenia Gravis-like Misleading Presentation: A Case Series in Intensive Care Unit. | J Clin Med | 2022 | 36233479 | PubTator, text mining | PubMed |
| Neuronal Agrin Promotes Proliferation of Primary Human Myoblasts in an Age-Dependent Manner. | Int J Mol Sci | 2022 | 36233091 | PubTator, text mining | PubMed |
| Axon Guidance Molecules and Pain. | Cells | 2022 | 36231105 | PubTator, text mining | PubMed |
| Use of Personalized Biomarkers in Metastatic Colorectal Cancer and the Impact of AI. | Cancers (Basel) | 2022 | 36230757 | PubTator, text mining | PubMed |
| A cell-based assay for detection of anti-fibrillarin autoantibodies with performance equivalent to immunoprecipitation. | Front Immunol | 2022 | 36225928 | PubTator, text mining | PubMed |
| Exploring the Potential Mechanism of Qi-Shen-Di-Huang Drug Formulary for Myasthenia Gravis (MG) based on UHPLC-QE-MS Network Pharmacology and Molecular Docking Techniques. | Evid Based Complement Alternat Med | 2022 | 36225188 | PubTator, text mining | PubMed |
| [Effects of rituximab on prognosis in myasthenia gravis: A single-center experience from Turkey]. | Ideggyogy Sz | 2022 | 36218113 | PubTator, text mining | PubMed |
| A Case Report and 31-Case Study: Does Takotsubo Cardiomyopathy in Myasthenia Gravis Patients Have a High Mortality Rate? | Cureus | 2022 | 36196306 | PubTator, text mining | PubMed |
| Abnormal decrement on high-frequency repetitive nerve stimulation in congenital myasthenic syndrome with GFPT1 mutations and review of literature. | Front Neurol | 2022 | 36188410 | PubTator, text mining | PubMed |
| Editorial: Phenotypes of myasthenia gravis. | Front Neurol | 2022 | 36188382 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4593/papers?page=37